Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
Nerivio
Theranica’s migraine DTx receives FDA clearance for adolescent use
By
Mallory Hackett
|
12:46 pm |
January 25, 2021
Nerivio is a wireless, noninvasive remote electrical-stimulation wearable that is worn on the upper arm at the onset of a migraine.
